In Cowden syndrome, PTEN inactivation elevates FTC risk through mutations, deletions, hypermethylation, or post-translational modifications, making PTEN a crucial predictive marker for thyroid cancer [57]. This evidence concerns the gene PTEN and Cowden disease.